Fuller & Thaler Asset Management’s Emergent Biosolutions EBS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$937K	Buy	112,910 +2,750	+2%	+$28.5K	﹤0.01%	395
2025 Q4	$1.36M	Sell	110,160 -1,900	-2%	-$20.4K	﹤0.01%	381
2025 Q3	$988K	Buy	112,060 +4,690	+4%	+$36.5K	﹤0.01%	392
2025 Q2	$685K	Sell	107,370 -40,110	-27%	-$230K	﹤0.01%	416
2025 Q1	$717K	Sell	147,480 -8,585	-6%	-$71.1K	﹤0.01%	418
2024 Q4	$1.49M	Buy	156,065 +170	+0.1%	+$1.56K	0.01%	387
2024 Q3	$1.3M	Sell	155,895 -583,930	-79%	-$5.31M	0.01%	373
2024 Q2	$5.05M	Sell	739,825 -35,800	-5%	-$154K	0.02%	314
2024 Q1	$1.96M	Buy	+775,625	New	+$1.75M	0.01%	379
2021 Q2	–	Sell	-503,405	Closed	-$46.8M	–	536
2021 Q1	$46.8M	Buy	503,405 +216,671	+76%	+$22.2M	0.33%	101
2020 Q4	$25.7M	Buy	286,734 +95,599	+50%	+$8.77M	0.24%	120
2020 Q3	$19.8M	Buy	+191,135	New	+$20.6M	0.25%	114
2019 Q2	–	Sell	-200,450	Closed	-$10.1M	–	466
2019 Q1	$10.1M	Buy	200,450 +6,683	+3%	+$394K	0.13%	145
2018 Q4	$11.5M	Sell	193,767 -13,388	-6%	-$863K	0.17%	126
2018 Q3	$13.6M	Sell	207,155 -8,879	-4%	-$518K	0.14%	136
2018 Q2	$10.9M	Buy	216,034 +794	+0.4%	+$41.4K	0.12%	142
2018 Q1	$11.3M	Sell	215,240 -6,400	-3%	-$319K	0.13%	127
2017 Q4	$10.3M	Buy	+221,640	New	+$9.33M	0.12%	122